Bottom line
How much do IBB and RYOIX overlap?
55% of their top holdings overlap by weight. 16 securities appear in both funds' top 25, making up 54.5% of IBB's assets and 39.1% of RYOIX's. They share a meaningful core but differ in the rest of the portfolio.
IBB holds far more positions (254 vs 74), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings IBB and RYOIX have in common
| Holding | % of IBB | % of RYOIX | Overlap |
|---|---|---|---|
| Vertex Pharmaceuticals, Inc. | 7.66% | 4.32% | 4.32% |
| Gilead Sciences, Inc. | 7.52% | 4.49% | 4.49% |
| Amgen, Inc. | 7.50% | 5.05% | 5.05% |
| Regeneron Pharmaceuticals, Inc. | 5.70% | 2.93% | 2.93% |
| Alnylam Pharmaceuticals, Inc. | 5.68% | 2.36% | 2.36% |
| Argenx SE | 3.15% | 1.48% | 1.48% |
| Insmed, Inc. | 2.95% | 1.79% | 1.79% |
| Natera, Inc. | 2.11% | 2.12% | 2.11% |
| BeOne Medicines Ltd. | 2.11% | 2.17% | 2.11% |
| Biogen, Inc. | 2.03% | 2.13% | 2.03% |
| United Therapeutics Corp. | 1.82% | 1.72% | 1.72% |
| Incyte Corp. | 1.62% | 1.62% | 1.62% |
| Illumina, Inc. | 1.41% | 1.94% | 1.41% |
| Neurocrine Biosciences, Inc. | 1.34% | 1.52% | 1.34% |
| Ionis Pharmaceuticals, Inc. | 1.03% | 1.35% | 1.03% |
| Moderna, Inc. | 0.88% | 2.15% | 0.88% |
Source: SEC Form N-PORT (periods Sep 30, 2025 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in IBB
- BlackRock Funds III — 13.18%
- IQVIA Holdings, Inc. — 3.18%
- Mettler-Toledo International, Inc. — 2.49%
- Waters Corp. — 1.77%
- Genmab A/S — 1.38%
- Medpace Holdings, Inc. — 1.16%
- Exelixis, Inc. — 1.07%
- BioMarin Pharmaceutical, Inc. — 1.02%
- Madrigal Pharmaceuticals, Inc. — 0.92%
Only in RYOIX
- Abbvie Inc — 8.17%
- Revolution Medicines Inc — 2.48%
- Royalty Pharma Plc — 2.01%
- Guardant Health Inc — 1.72%
- Roivant Sciences Ltd — 1.66%
- Viatris Inc — 1.55%
- Jazz Pharmaceuticals Plc — 1.42%
- Bridgebio Pharma Inc — 1.38%
- Cytokinetics Inc — 1.35%
Asset mix
| Asset type | IBB | RYOIX |
|---|---|---|
| Stocks | 99.8% | 99.6% |
| Cash & short-term funds | 13.4% | 0.6% |
| Repurchase agreements | — | 0.6% |
Source: SEC Form N-PORT (periods Sep 30, 2025 / Jun 30, 2026)
Country mix
| Country | IBB | RYOIX |
|---|---|---|
| US | 98.6% | 85.8% |
| NL | 4.3% | 1.5% |
| CH | 2.7% | 3.3% |
| GB | 1.0% | 3.2% |
| IE | 0.5% | 2.7% |
| DK | 2.2% | 0.9% |
| BM | 0.7% | 1.7% |
| DE | 0.7% | 1.2% |
Source: SEC Form N-PORT (periods Sep 30, 2025 / Jun 30, 2026)
Check another pair
FAQ
How much do IBB and RYOIX overlap?
What stocks do IBB and RYOIX have in common?
Should I own both IBB and RYOIX?
Which holds more stocks, IBB or RYOIX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.